Background: Left ventricular hypertrophy (LVH) has been identified as a main target organ change resulting from hypertension, also being a long-term predictor of myocardial infarction, stroke and cardiovascular death. However, very few longitudinal studies exist following the development of LVH in the hypertensive process. Methods: The present longitudinal study investigated a population based group of borderline hypertensive men (BHT, n = 66, diastolic blood pressure (BP) 85-94 mm Hg). M-mode echocardiography was performed at baseline and after 3 years, and anthropometrical data recorded. Results: There was no increase in LVH indices over the 3-year period, while there was a statistically significant increase in aortic root dimension (P Ͻ 0.001), left atrial
Introduction
Left ventricular hypertrophy (LVH) has been identified as one of the target organ changes belonging to hypertension, and also as a long-term predictor of myocardial infarction, stroke and cardiovascular death. 1 Factors that have been shown to influence the development of LVH are age, blood pressure (BP) levels and body size. [2] [3] [4] [5] Almost all of the studies on the effect of age, body size and BP on development of LVH are based on cross-sectional, rather than longitudinal, studies. [2] [3] [4] [5] These cross-sectional studies have consistently shown LVH to increase with age, and to be related to body size and BP levels. In a study by Pearson et al 5 the average increase in left ventricular mass index (LVMI) was estimated to be 0.25 g/m 2 per year. A study by Lima et al 6 showed systolic BP (SBP) to be the main determinant of ageassociated increase in LVH. However, in a study of the healthy participants of the Framingham study it was shown that LVH did not seem to increase significantly with age and SBP, whereas height and body mass index (BMI) had a significant influence diameter in diastole (LADD, P Ͻ 0.001), left ventricular diameter in diastole (LVDD, P Ͻ 0.001) and peak systolic wall stress (PSWS, P Ͻ 0.01) and a significant decrease in left ventricular ejection time (LVET, P Ͻ 0.01). Baseline BP levels correlated to PSWS (P Ͻ 0.05) but not to LVH indices, whereas body mass index (BMI) correlated significantly to wall thickness (P Ͻ 0.05) and LV mass (P Ͻ 0.05). Conclusions: LVH indices did not increase over a 3-year period. However, there was a significant increase in aortic root dimension, LADD, LVDD and PSWS, and a significantly shortened LVET, suggesting that these changes precede any increase in LVH. Finally, BMI showed stronger correlation to LVH indices than did BP levels.
on LV mass. 7 In a small longitudinal 5-year study in borderline hypertension by Sivertsson et al 8 there was a significant thickening of the septum and posterior wall although BP levels were essentially unchanged.
LV mass and wall thickness are not the only variables influenced by age and BP levels. In several cross-sectional studies variables such as aortic root dimension, 9,10 left atrial dimension and LV dimension in diastole have been shown to increase with age. 9 The aim of the present study was to evaluate changes in cardiac structure in a longitudinal 3-year study in otherwise healthy, borderline hypertensive men. Such a longitudinal study of the effects of a mildly elevated BP in a well controlled population could help further elucidate the respective roles of age, changes in body mass and BP in the development of LVH and other structural cardiac changes.
Subjects and methods

Study groups
In 1985 a BP screening programme was started in Åkersberga, a small community 35 kilometers north of Stockholm, Sweden. All men aged 35 to 55 years were asked, by mail, to visit the primary health care centre and have their BP measured. As has been described earlier 11 193 patients with borderline hypertension (BHT), defined as a diastolic BP (DBP) of 85-94 mm Hg measured repeatedly over several weeks, were identified. These individuals were followed up with yearly visits for 3 years. At these controls approximately 20% of the subjects become hypertensive and 20% normotensive with the major change (13-15%) occurring already at the 1 year control. After 3 years 81 men were still within the range of BHT on the basis of repeated measurements over the entire time period. All BP measurements during the entire recruitment procedure and study period were performed by one and the same person, a specially trained nurse.
The study was approved by the local ethics committee of Karolinska Hospital and conducted in accordancce with the Helsinki Declaration. All subjects gave their informed consent before entering both the initial screening and the extended 3-year follow-up. Of the 81 men with BHT who accepted to participate two patients in the BHT group discontinued the study programme and 10 of the patients did not complete echocardiography at the 3-year follow-up. None of the subjects had any signs of metabolic or ischaemic heart disease or were using any drugs known to influence BP or cardiac structure.
Study programme
BP measurements: An identical procedure was followed at each occasion during the entire recruitment period. All BP measurements were performed with a mercury sphygmomanometer. The cuff was adjusted according to the circumference of the arm and placed at the level of the heart. BP was recorded as the mean of two measurements taken after a 5-min rest in the supine position. Systolic and diastolic BP were defined according to Korotkoff I and V. The same specially trained nurse performed the measurements at all occasions.
Echocardiographic measurements: LV wall thickness was assessed by M-mode echocardiography at baseline and 3 years as described earlier. 11 Recording techniques and measurements of LV diameters and wall thicknesses were performed in accordance with recommendations from the American Society of Echocardiography. All recordings at baseline and 3 years were performed by the same technician following the same standardised protocol. The following variables were measured or calculated: aortic root dimension, left atrial diameter in diastole (LADD); left ventricular diameter in diastole (LVDD), left ventricular diameter in systole (LVDS), septum thickness in diastole (STD), posterior wall thickness in diastole (PWTD), left ventricular mass (LVM) according to Devereux et al 12 and left ventricular ejection time (LVET). Since body size is a factor closely correlated to the LVM, 4 left ventricular mass index (LVMI) was calculated as LVM divided by body surface area (BSA). 13 Peak systolic wall stress (PSWS) was calculated as:
where p = resting SBP, D = LVDD and h = (STD + PWTD)/2.
14 Body stature: The same procedure was used on both occasions and performed by the same nurse. All patients were weighed without clothing other than underwear, using the same scale (Delta 707, SECA, Germany). Length was measured with a special ruler, fixed to the wall. Waist circumference was measured at the level of the umbilicus and the hips were measured at the level of the greatest circumference. BMI was subsequently calculated as weight in kilograms/(height in meters) 2 .
Metabolic variables: At baseline there were no measurements of metabolic variables but at the 3-year follow-up fasting venous blood samples for determination of blood glucose (Kodak Ectachem, Germany) and plasma insulin (radio immunoassay: Kabi Pharmacia, Sweden) were taken. Insulin resistance (IR) was calculated from fasting serum insulin and blood glucose levels using a computer-solved homeostasis model assessment 15 :
.
Statistical methods
Variables were tested for skewness. For skewed variables non-parametric tests were used for comparisons between the two occasions, whereas a onefactor ANOVA for paired, repeated measurements was used for normally distributed variables. Correlation analysis was performed to determine interactions between original BP and BMI levels, and subsequent signs of LVH and cardiac structural changes. A stepwise multiple regression analysis (using F = 4 to enter) was performed to assess the influence of BP, age and BMI on echocardiographical variables. A P Ͻ 0.05 was considered as statistically significant. Values in the text are given as mean ± standard deviation.
Results
Characteristics of cases
Of the 69 patients who had an echocardiography performed at the 3-year follow-up, 66 had an evaluable registration from the start of the study. Basic characteristics at baseline and 3-year follow-up are presented in Table 1 . There was a slight, but statisti- Values are given as mean (±s.d.). Bpm = beats per minute; BMI = body mass index; BSA = body surface area. Differences between baseline and 3-year follow-up tested with one factor ANOVA for repeated measures. *P Ͻ 0.05 vs baseline. cally significant rise in DBP over the 3 years, while the SBP did not change significantly. There was also a slight rise in BMI, corresponding to a weight increase of 0.6 kg but this was not statistically significant. Finally, there was a slight but significant decrease in heart rate.
Comparisons of echocardiographic variables at baseline and at 3 years
See Table 2 for details. There was no significant increase in STD, PWTD, LVM or LVMI. The aortic root and the left atrial diameter in diastole, as well as the LVDD, increased significantly over the 3 years in the group as a whole, although individual variation was evident (individual data for LVDD are shown in Figure 1 ). PSWS increased significantly while LVET decreased significantly. 
Relations between age, baseline levels of BP and BMI, subsequent metabolic and smoking status and changes in echocardiographic variables
The subjects age at baseline did not correlate significantly with any of the different LVH indices after 3 years (LVHI-3) or with the change in LVH indices over the 3 years (⌬LVHI). However, there was a significant correlation between age at baseline and LVET at 3 years (r = 0.28, P Ͻ 0.05).
The DBP-b showed no correlation, neither to ⌬LVHI nor LVHI-3. There were, as expected, significant correlations between DBP-b and change in DBP (⌬DBP) and SBP (⌬SBP) over the 3 years (r = 0.92, P Ͻ 0.001 and r = 0.28, P Ͻ 0.05, respectively).
SBP-b exhibited no correlation to ⌬LVHI or LVHI-3. However, there was a significant correlation between SBP-b and PSWS-3 (r = 0. 30, P Ͻ 0.05) but not between SBP-b and ⌬PSWS (r = 0.08). There was a trend towards correlation between SBP-b and ⌬LVET, but this did not quite reach statistical significance (r = 0.27, P = 0.052). Furthermore, SBP-b was strongly correlated to ⌬SBP and ⌬DBP (r = 0.48, P Ͻ 0.001 and r = 0.29, P Ͻ 0.05, respectively) and to SBP-3 (r = 0.49, P Ͻ 0.001).
BMI-b was correlated with 3-year levels of left atrial diameter (LAD-3), PWTD (PWTD-3) and LVM (LVM-3) (r = 0.36, P Ͻ 0.005, r = 0.29, P Ͻ 0.05 and r = 0.27, P Ͻ 0.05, respectively) but not to change in the same variables over the 3 years (r = 0.07-0.20, P Ͼ 0.10).
A stepwise multiple regression analysis was performed taking into consideration age at baseline, BP levels (baseline and change over 3 years) and BMI (baseline and change over 3 years). The analysis confirmed the above findings, showing baseline BMI to be the single significant factor for LVDD-3 (F = 9.12), PWTD-3 (F = 5.59) and LVM-3 (F = 4.97), whereas SBP-b was the single significant factor for PSWS-3 (F = 6.34) and age for LVET-3 (F = 9.21).
When comparing those individuals who exhibited an increase in left ventricular dimensions (UP, n = 36) with those who exhibited no change or a decrease (NC, n = 27) there were no differences in baseline or 3-year BP levels. The BMI, insulin levels and insulin resistance index at 3 years in the UP group were all higher than in the NC group, but not significantly so (26.1 vs 25.7 kg/m 2 , 18.1 vs 16.8 mU/ml and 4.2 vs 3.7, respectively).
Since no baseline measurements were performed of the individuals metabolic or smoking status a prospective evaluation of the influence of these factors cannot be done. However, it can be noted that those individuals who smoked after 3 years (n = 22) had significantly larger increases in STD (0.43 ± 1.96 vs−0.65 ± 1.69 mm, P = 0.029), SBP (4.8 ± 10.3 vs 0.8 ± 8.7 mm Hg, P = 0.025) and a tendency to larger decrease in LVET (−2.25 ± 3.73 vs −0.73 ± 3.12 s, NS).
Discussion
In the present longitudinal 3-year follow-up study of borderline hypertensive men there is no statistically significant increase in different indices of LVH during the study period. However, despite individual variability statistically significant changes occur during the 3 years, affecting diastolic dimensions of the aorta, left atrium and left ventricle as well as peak systolic wall stress and ejection time. These latter findings are in accordance with the results of Badano et al 9 and Dahan et al. 10 They indicate that these types of adaptations occur early on in the hypertensive process, pointing to the possibility of these variables being more pressure sensitive. The findings are further strengthened by the recently reported results of Schmeider et al 16 showing that in borderline hypertension there is a central shift of blood volume, accompanied by increased diastolic diameters, whereas established hypertension exhibits normal volume distribution and increases in ventricular mass. 16 In the present study there were no correlations between SBP and LVH indices, whereas there was a significant correlation to PSWS. The findings of increases in PSWS alongside decreasing LVET also correspond well to previous findings in early hypertension. 17, 18 Together these results suggest that the first structural adaptations to occur during the hypertensive process are increases in diastolic dimensions, coupled with a rising wall stress and shortened ejection time.
This suggested sequence of events could also explain the absence of increase in LVH indices in the present study. The cross-sectional studies previously referred to 2, 3, 5 have, in general, studied age differences of considerably more than 3 years. A period of 3 years can be too short a time for hypertrophic changes to become evident, despite the presence of modestly elevated BP. Nevertheless, the results do to some extent favour the conclusion reached by Dannenberg et al 7 that in a population without elevated risk factors such as significantly increasing BP and obesity, LVM does not necessarily increase with age.
Many studies have shown that casual BP levels do not correlate particularly well with echocardiographically determined LVH. 4, 19, 20 In a previously reported cross-sectional study of these borderline hypertensive men ambulatory BPs were a far better determinant of LVH indices and we also demonstrated that in normotensive men variables such as BMI had a greater impact on LV mass than did BP levels. 11 The same results are evident in the present study. Casual BP levels had no significant correlation to LVH indices either at baseline or at 3 years and BP levels did not differ significantly between those individuals who exhibited increases and those who did not. Baseline BMI, on the other hand, correlated significantly to LVH indices both at baseline and at 3 years. This further strengthens the notion that at discreetly elevated BP levels, as in borderline hypertension, BMI rather than the BP levels per se, is a stronger determinant for development of LVH.
The echocardiographic method itself, though widely used, is not without methodological problems. In this study all subjects were examined by the same technician at both occasions, using an identical procedure at each occasion. All recordings from the respective occasions were evaluated at the same time, thus minimising variablity and bias.
In conclusion it can be stated that at the modestly elevated BP levels within the range of borderline hypertension there is no significant increase in LV mass over a period of 3 years follow-up. However, during the same period there is a significant increase in diastolic dimensions of the aortic root, left atrium and left ventricle, coupled with an increase in peak systolic wall stress and a shortened ejection time, suggesting that these changes preceed any increase in LVH. Finally, over a 3-year period factors such as BMI seem to be of greater importance for changes in LVH indices in borderline hypertension than do casual BP levels.
